Recommendations for cardiac pacing after transcatheter aortic valve implantation
 |
|
AF = atrial fibrillation; AVB = atrioventricular block; BBB = bundle branch block; CRT = cardiac resynchronization therapy; ECG = electrocardiogram; EPS = electrophysiology study; HV = His–ventricular interval; LBBB = left bundle branch block; RBBB = right bundle branch block; SR = sinus rhythm; TAVI = transcatheter aortic valve implantation. For the definition of alternating BBB, see section 5.3.1.
Class of recommendation.
Level of evidence.
Immediately after procedure or within 24 h.
Transient high-degree AVB, PR prolongation, or QRS axis change.
Ambulatory continuous ECG monitoring (implantable or external) for 7–30 days.536,549
EPS should be performed ≥3 days after TAVI. Conduction delay with HV ≥70 ms may be considered positive for permanent pacing.540,541,550
With no further prolongation of QRS or PR during 48-h observation.
Note: CRT in patients requiring pacing after TAVI has the same indication as for general patients (see section 6).
Recommendations for cardiac pacing after transcatheter aortic valve implantation
|
|
AF = atrial fibrillation; AVB = atrioventricular block; BBB = bundle branch block; CRT = cardiac resynchronization therapy; ECG = electrocardiogram; EPS = electrophysiology study; HV = His–ventricular interval; LBBB = left bundle branch block; RBBB = right bundle branch block; SR = sinus rhythm; TAVI = transcatheter aortic valve implantation. For the definition of alternating BBB, see section 5.3.1.
Class of recommendation.
Level of evidence.
Immediately after procedure or within 24 h.
Transient high-degree AVB, PR prolongation, or QRS axis change.
Ambulatory continuous ECG monitoring (implantable or external) for 7–30 days.536,549
EPS should be performed ≥3 days after TAVI. Conduction delay with HV ≥70 ms may be considered positive for permanent pacing.540,541,550
With no further prolongation of QRS or PR during 48-h observation.
Note: CRT in patients requiring pacing after TAVI has the same indication as for general patients (see section 6).
